Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Centre for Drug Research and Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014163
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Centre for Drug Research and Development (CDRD) is a drug development and commercialization center that provides infrastructure to transform basic health research in academic institutions and early-stage therapeutic technologies into new medicines. The center offers target validation, screening, drug delivery, medicinal chemistry, pharmacology and toxicology, biologics and external platforms. It spans its expertise in the therapeutic areas of neuroscience, oncology, inflammation, fibrosis and others. CDRD’s target validation programs comprise vivo efficacy model development, assay development and transfer, and others. The center has also established national, provincial, and international partnerships, and developed specially-trained highly-qualified personnel. CDRD is headquartered in Vancouver, British Columbia, Canada.

Centre for Drug Research and Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Centre for Drug Research and Development, Medical Devices Deals, 2011 to YTD 2017 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 12
Partnerships 13
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 13
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 14
Centre for Drug Research and Development Partners with AstraZeneca 15
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 16
The Centre For Drug Research Enters Into Co-Development Agreement With F. Hoffmann-La Roche 17
CDRD Enters Into Preferred Collaboration With National Research Council 18
CDRD Enters Into An Agreement With Lead Discovery Center 19
CDRD Enters Into Co-Development Agreement With PANAMP 20
CDRD Enters Into Co-Development Agreement With NGDI-UBC 21
Licensing Agreements 22
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 22
Centre for Drug Research and Development – Key Competitors 23
Centre for Drug Research and Development – Key Employees 24
Centre for Drug Research and Development – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Corporate Communications 26
May 01, 2017: CDRD appoints CFO 26
May 01, 2017: CDRD Appoints Matthew J. Carlyle Chief Financial Officer 27
Feb 01, 2017: CDRD Appoints Gordon McCauley as President and CEO 28
Sep 09, 2016: Zucara Therapeutics appoints Michael Midmer as CEO 29
Government and Public Interest 30
Mar 09, 2017: Stem Cell & Regenerative Medicine Leaders Join Forces to Advance Canada’s Position in the Field 30
Nov 23, 2016: Transforming drug research and development in B.C. 31
Product News 32
Jun 27, 2017: LifeArc, Dstl and CDRD Collaborate to Identify Antibacterial Drug Targets 32
Other Significant Developments 33
Jun 08, 2016: CDRD Collaborator ImStar Therapeutics Receives Investment by Accel-Rx 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Key Facts 2
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Centre for Drug Research and Development, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Centre for Drug Research and Development, Deals By Therapy Area, 2011 to YTD 2017 8
Centre for Drug Research and Development, Medical Devices Deals, 2011 to YTD 2017 9
Centre for Drug Research and Development, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Zucara Therapeutics Raises USD0.4 Million in Venture Financing 12
Aequus Pharma and Centre for Drug Research and Development Enter into a Research Agreement 13
Novelogics Biotech Enters into Research Agreement with Centre for Drug Research and Development 14
Centre for Drug Research and Development Partners with AstraZeneca 15
Centre for Drug Research and Development Enters into Agreement with viDA Therapeutics 16
The Centre For Drug Research Enters Into Co-Development Agreement With F. Hoffmann-La Roche 17
CDRD Enters Into Preferred Collaboration With National Research Council 18
CDRD Enters Into An Agreement With Lead Discovery Center 19
CDRD Enters Into Co-Development Agreement With PANAMP 20
CDRD Enters Into Co-Development Agreement With NGDI-UBC 21
Zucara Therapeutics Enters into Licensing Agreement with Centre for Drug Research and Development 22
Centre for Drug Research and Development, Key Competitors 23
Centre for Drug Research and Development, Key Employees 24

★海外企業調査レポート[Centre for Drug Research and Development-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Electromed Inc (ELMD):企業の財務・戦略的SWOT分析
    Summary Electromed Inc (Electromed) is a medical device company that designs, manufactures and markets respiratory care products using airway clearance technologies. The company offers smartvest airway clearance system used through in-home and in-patient therapies for respiratory treatments. It offe …
  • Nidec Corporation (6594):企業の財務・戦略的SWOT分析
    Nidec Corporation (6594) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • North Asia Strategic Holdings Limited:企業の戦略・SWOT・財務分析
    North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary North Asia Strategic Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Banque Cantonale de Geneve Private Banking:企業の戦略・SWOT・財務情報
    Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report Summary Banque Cantonale de Geneve Private Banking - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, …
  • Meera Industries Ltd (540519):企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Sino-Ocean Group Holding Limited:企業の戦略・SWOT・財務情報
    Sino-Ocean Group Holding Limited - Strategy, SWOT and Corporate Finance Report Summary Sino-Ocean Group Holding Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Zehnder Group AG (ZEHN):企業の財務・戦略的SWOT分析
    Zehnder Group AG (ZEHN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Baker Hughes, a GE Co LLC (BHGE):企業の財務・戦略的SWOT分析
    Baker Hughes, a GE Co LLC (BHGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Illovo Sugar Africa Pty Ltd:企業の戦略的SWOT分析
    Illovo Sugar Africa Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • Ono Pharmaceutical Co Ltd (4528):製薬・医療:M&Aディール及び事業提携情報
    Summary Ono Pharmaceutical Co Ltd (Ono Pharmaceutical) is a focuses on the research, development, manufacture and sale of prescription pharmaceuticals and diagnostic reagents. Its product portfolio includes pharmaceuticals for the treatment of type II diabetes, overactive bladder, osteoporosis, Alzh …
  • Oxford BioMedica Plc (OXB):製薬・医療:M&Aディール及び事業提携情報
    Summary Oxford BioMedica plc (Oxford Biomedica) is a gene and cell therapy company that focuses on developing novel treatments for serious diseases. The company along with its subsidiaries has developed LentiVector, a sector leading lentiviral vector delivery platform. It has also built a platform o …
  • Biafo Industries Ltd (BIFO):企業の財務・戦略的SWOT分析
    Biafo Industries Ltd (BIFO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Altius Minerals Corp:企業の戦略・SWOT・財務分析
    Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report Summary Altius Minerals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • DTE Energy Co (DTE):企業の財務・戦略的SWOT分析
    DTE Energy Co (DTE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • CSS Industries, Inc. (CSS):企業の財務・戦略的SWOT分析
    CSS Industries, Inc. (CSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • JSW Steel Ltd:企業のM&A・事業提携・投資動向
    JSW Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JSW Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Italgas SpA-石油・ガス分野:企業M&A・提携分析
    Summary Italgas SpA (Italgas), a subsidiary of Snam SpA, is an oilfield service company that offers transportation and dispatching of natural gas, liquefied natural gas regasification, and storage and distribution of natural gas. The company's activities include rhino-analytical tests; instrumental …
  • Verizon Connect:企業の戦略的SWOT分析
    Verizon Connect - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Salzgitter AG:企業の戦略・SWOT・財務情報
    Salzgitter AG - Strategy, SWOT and Corporate Finance Report Summary Salzgitter AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Epigenomics AG (ECX):製薬・医療:M&Aディール及び事業提携情報
    Summary Epigenomics AG (Epigenomics) is a molecular diagnostics company which develops and commercializes in-vitro diagnostic (IVD) tests for screening, early detection and diagnosis of cancer. Its lead product, Epi proColon is a blood-based test for rapid detection of colorectal cancer; and Epi pro …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆